These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15284532)

  • 21. The novel UGT1A9 intronic I399 polymorphism appears as a predictor of 7-ethyl-10-hydroxycamptothecin glucuronidation levels in the liver.
    Girard H; Villeneuve L; Court MH; Fortier LC; Caron P; Hao Q; von Moltke LL; Greenblatt DJ; Guillemette C
    Drug Metab Dispos; 2006 Jul; 34(7):1220-8. PubMed ID: 16595709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. UGT1A1*28 genotype affects the in-vitro glucuronidation of thyroxine in human livers.
    Yoder Graber AL; Ramírez J; Innocenti F; Ratain MJ
    Pharmacogenet Genomics; 2007 Aug; 17(8):619-27. PubMed ID: 17622938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevalence of uridine diphosphate-glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T and its influence on mycophenolic acid pharmacokinetics in stable renal transplant patients.
    Sánchez-Fructuoso AI; Maestro ML; Calvo N; Viudarreta M; Pérez-Flores I; Veganzone S; De la Orden V; Ortega D; Arroyo M; Barrientos A
    Transplant Proc; 2009; 41(6):2313-6. PubMed ID: 19715905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for regulation of UDP-glucuronosyltransferase (UGT) 1A1 protein expression and activity via DNA methylation in healthy human livers.
    Yasar U; Greenblatt DJ; Guillemette C; Court MH
    J Pharm Pharmacol; 2013 Jun; 65(6):874-83. PubMed ID: 23647681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between the UDP-glucuronosyltransferase (UGT1A1) TATAA box polymorphism and carcinogen detoxification phenotype: significantly decreased glucuronidating activity against benzo(a)pyrene-7,8-dihydrodiol(-) in liver microsomes from subjects with the UGT1A1*28 variant.
    Fang JL; Lazarus P
    Cancer Epidemiol Biomarkers Prev; 2004 Jan; 13(1):102-9. PubMed ID: 14744740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional characterization of human UDP-glucuronosyltransferase 1A9 variant, D256N, found in Japanese cancer patients.
    Jinno H; Saeki M; Saito Y; Tanaka-Kagawa T; Hanioka N; Sai K; Kaniwa N; Ando M; Shirao K; Minami H; Ohtsu A; Yoshida T; Saijo N; Ozawa S; Sawada J
    J Pharmacol Exp Ther; 2003 Aug; 306(2):688-93. PubMed ID: 12730278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of UGT1A9 intronic I399C>T polymorphism on SN-38 glucuronidation in Asian cancer patients.
    Sandanaraj E; Jada SR; Shu X; Lim R; Lee SC; Zhou Q; Zhou S; Goh BC; Chowbay B
    Pharmacogenomics J; 2008 Jun; 8(3):174-85. PubMed ID: 17700594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haplotypes of variants in the UDP-glucuronosyltransferase1A9 and 1A1 genes.
    Innocenti F; Liu W; Chen P; Desai AA; Das S; Ratain MJ
    Pharmacogenet Genomics; 2005 May; 15(5):295-301. PubMed ID: 15864130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of uridine diphosphate (UDP)-glucuronosyltransferases and ABCC2 genetic polymorphisms on the pharmacokinetics of mycophenolic acid and its metabolites in Chinese renal transplant recipients.
    Zhang WX; Chen B; Jin Z; Yu Z; Wang X; Chen H; Mao A; Cai W
    Xenobiotica; 2008 Nov; 38(11):1422-36. PubMed ID: 18946804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel polymorphism in the promoter region of human UGT1A9 gene (UGT1A9*22) and its effects on the transcriptional activity.
    Yamanaka H; Nakajima M; Katoh M; Hara Y; Tachibana O; Yamashita J; McLeod HL; Yokoi T
    Pharmacogenetics; 2004 May; 14(5):329-32. PubMed ID: 15115919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of sex on propofol metabolism, a pilot study: implications for propofol anesthesia.
    Loryan I; Lindqvist M; Johansson I; Hiratsuka M; van der Heiden I; van Schaik RH; Jakobsson J; Ingelman-Sundberg M
    Eur J Clin Pharmacol; 2012 Apr; 68(4):397-406. PubMed ID: 22006347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between UDP-glucuronosyltransferase genotypes and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone glucuronidation phenotype in human liver microsomes.
    Wiener D; Fang JL; Dossett N; Lazarus P
    Cancer Res; 2004 Feb; 64(3):1190-6. PubMed ID: 14871856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of UDP-glucuronosyltransferase 1A9 (UGT1A9) gene polymorphism with kidney allograft function.
    Pazik J; Ołdak M; Dąbrowski M; Lewandowski Z; Sitarek E; Podgórska M; Ważna E; Płoski R; Szmidt J; Chmura A; Durlik M; Malejczyk J
    Ann Transplant; 2011; 16(4):69-73. PubMed ID: 22210424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterizing the effect of UDP-glucuronosyltransferase (UGT) 2B7 and UGT1A9 genetic polymorphisms on enantioselective glucuronidation of flurbiprofen.
    Wang H; Yuan L; Zeng S
    Biochem Pharmacol; 2011 Dec; 82(11):1757-63. PubMed ID: 21856293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms.
    Court MH; Duan SX; von Moltke LL; Greenblatt DJ; Patten CJ; Miners JO; Mackenzie PI
    J Pharmacol Exp Ther; 2001 Dec; 299(3):998-1006. PubMed ID: 11714888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocyte nuclear factor1 transcription factors are essential for the UDP-glucuronosyltransferase 1A9 promoter response to hepatocyte nuclear factor 4alpha.
    Gardner-Stephen DA; Mackenzie PI
    Pharmacogenet Genomics; 2007 Jan; 17(1):25-36. PubMed ID: 17264800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: I. Identification of polymorphisms in the 5'-regulatory and exon 1 regions, and association with human liver UGT1A6 gene expression and glucuronidation.
    Krishnaswamy S; Hao Q; Al-Rohaimi A; Hesse LM; von Moltke LL; Greenblatt DJ; Court MH
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1331-9. PubMed ID: 15761114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. UGT1A1 and UGT1A9 functional variants, meat intake, and colon cancer, among Caucasians and African-Americans.
    Girard H; Butler LM; Villeneuve L; Millikan RC; Sinha R; Sandler RS; Guillemette C
    Mutat Res; 2008 Sep; 644(1-2):56-63. PubMed ID: 18675828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regioselective glucuronidation of the isoflavone calycosin by human liver microsomes and recombinant human UDP-glucuronosyltransferases.
    Ruan JQ; Yan R
    Chem Biol Interact; 2014 Sep; 220():231-40. PubMed ID: 25044472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal development of hepatic UGT1A9: implications of pediatric pharmacokinetics.
    Miyagi SJ; Milne AM; Coughtrie MW; Collier AC
    Drug Metab Dispos; 2012 Jul; 40(7):1321-7. PubMed ID: 22492655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.